Welcome to Sequence Card of Peptide


Details of CancerPDF entry with Sequence SPMYSIITPNILR
Primary information
sequence IDSeq_7481
Peptide sequenceSPMYSIITPNILR
CancerPDF_ID CancerPDF_ID1467, CancerPDF_ID1522, CancerPDF_ID2690, CancerPDF_ID11072,
PMID21136997,21136997,21136997,27043541
Protein NameComplement C3,Complement C3,Complement C3,CO3_HUMAN
UniprotKB Entry NameCO3_HUMAN,CO3_HUMAN,CO3_HUMAN,CO3_HUMAN
FluidSerum,Serum,Plasma,Serum
M/Z1503.81194,1519.80685,1503.8119,1520.8456
Charge1,1,1,NA
Mass (in Da)NA,NA,NA,NA
fdrNA,NA,NA,NA
Profiling TechniqueLC-MS,LC-MS,LC-MS,MALDI-TOF
Peptide Identification techniqueLC-MS-MS/MS,LC-MS-MS/MS,LC-MS-MS/MS,LC-MALDI-TOF/TOF-MS/MS
Quantification TechniqueLC-ESI-MS,LC-ESI-MS,LC-ESI-MS,NA
Labelled/Label FreeLabel Free,Label Free,Label Free,Label Free
FDRNA,NA,NA,NA
CancerPDF_ID CancerPDF_ID1467, CancerPDF_ID1522, CancerPDF_ID2690, CancerPDF_ID11072,
p-ValueNA,NA,NA,NA
SoftwareMASCOT(v. 2.2.01),MASCOT(v. 2.2.01),MASCOT(v. 2.2.01),MASCOT
Length13,13,13,13
Cancer TypeColorectal cancer,Colorectal cancer,Normal,Non-small cell lung cancer (NSCLC)
DatabaseSwissProt Database,SwissProt Database,SwissProt Database,SwissProt Database
ModificationNA,Oxidation of Met,NA,phosphorylation
Number of Patients30 patients and 30 healthy controls,30 patients and 30 healthy controls,27 healthy individuals,477 patients and healthy controls
RegulationNA,NA,NA,Differentially expressed between cancer vs normal
ValidationLeave One out Cross validation,Leave One out Cross validation,Leave One out Cross validation,external cross validation done
SensitivityNA,NA,NA,NA
SpecificityNA,NA,NA,NA
AccuracyNA,NA,NA,NA
Peptide AtlasPeptideAtlas
IEDB153006